Mark Samuels

As CEO of Medicines UK, Mark represents the companies supplying nine out of ten NHS medicines, and he has served on the government’s Life Sciences Council since 2022. Earlier in his career, he was the founding Managing Director of the government’s Office for Clinical Research Infrastructure. Mark served on the National Institute for Health Research Board with a £1.1bn/year budget. He was previously an executive at Roche, and, in France and the Netherlands, at Unilever. Mark is a graduate of QMUL and Oxford’s Saïd Business School. He has completed a Policy Fellowship at Cambridge University and the Leading Economic Growth programme at Harvard.